95 related articles for article (PubMed ID: 11605064)
1. Plasma and tissue prolactin detection in colon carcinoma.
Indinnimeo M; Cicchini C; Memeo L; Stazi A; Ghini C; Ricci F; Reale MG; Mingazzini P
Oncol Rep; 2001; 8(6):1351-3. PubMed ID: 11605064
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between hyperprolactinemia and colon carcinoma.
Carlson HE; Zarrabi MH; Lyubsky SL
Cancer Invest; 2000; 18(2):130-4. PubMed ID: 10705875
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and colorectal cancer: is there a connection?
Baert D; Matthys C; Gillardin JP; Lepoutre L; Thienpont L; Kaufman JM; Cuvelier C; De Vos M
Acta Gastroenterol Belg; 1998; 61(4):407-9. PubMed ID: 9923090
[TBL] [Abstract][Full Text] [Related]
4. Ectopic prolactin secretion from a perivascular epithelioid cell tumor (PEComa).
Korytnaya E; Liu J; Camelo-Piragua S; Sullivan S; Auchus RJ; Barkan A
J Clin Endocrinol Metab; 2014 Nov; 99(11):3960-4. PubMed ID: 25127092
[TBL] [Abstract][Full Text] [Related]
5. Plasma and tumor prolactin in colorectal cancer patients.
Ilan Y; Sibirsky O; Livni N; Gofrit O; Barack V; Goldin E
Dig Dis Sci; 1995 Sep; 40(9):2010-5. PubMed ID: 7555457
[TBL] [Abstract][Full Text] [Related]
6. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology of hyperprolactinemia in breast cancer].
Holtkamp W; Wuttke W; Nagel GA; Michel U; Rauschecker H
Onkologie; 1988 Apr; 11(2):86-103. PubMed ID: 3041329
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of serum prolactin in patients with advanced multiple myeloma.
Gadó K; Rimanóczi E; Hasitz A; Gigler G; Tóth BE; Nagy GM; Pálóczi K; Domján G
Neuroimmunomodulation; 2001; 9(4):231-6. PubMed ID: 11847486
[TBL] [Abstract][Full Text] [Related]
9. Prolactin: its role in advanced tongue cancer.
Bhatavdekar JM; Patel DD; Vora HH; Shah NG; Karelia NH; Ghosh N; Balar DB
J Surg Oncol; 1994 Oct; 57(2):115-20. PubMed ID: 7934062
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
Paraiba DB; Soares CR; Bartolini P; Arthuso FS; Borba EF; Bonfa E; Bronstein MD
Clin Exp Rheumatol; 2010; 28(6):866-72. PubMed ID: 21205462
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
[TBL] [Abstract][Full Text] [Related]
12. Expression of functional prolactin and its receptor in human colorectal cancer.
Otte JM; Otte C; Beckedorf S; Schmitz F; Vonderhaar BK; Fölsch UR; Kloehn S; Herzig KH; Mönig H
Int J Colorectal Dis; 2003 Jan; 18(1):86-94. PubMed ID: 12458387
[TBL] [Abstract][Full Text] [Related]
13. [Misleading diagnosis of hyperprolactinemia in women].
Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
[TBL] [Abstract][Full Text] [Related]
14. Absence of prolactin gene expression in colorectal cancer.
Wood AJ; Thomas CM; Baumforth KR; Flavell JR; Scott KW; Grace RH; Williams JG; Holland MR; Dunn R; Jacobs AG; Harrison A; Brun S; Plessis N; Murray PG
Mol Pathol; 1999 Jun; 52(3):135-9. PubMed ID: 10621834
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclosporine on circulating levels of prolactin, LH, FSH, TSH and GH in chronic hyperprolactinemic male rats.
Lafuente A; Alvarez-Demanuel E; Blanco A; García-Bonacho M; Esquifino AI
Rev Esp Fisiol; 1996 Sep; 52(3):161-6. PubMed ID: 8974151
[TBL] [Abstract][Full Text] [Related]
16. Superior cervical ganglionectomy differentially modifies median eminence and anterior and mediobasal hypothalamic GABA content in male rats: effects of hyperprolactinemia.
Esquifino AI; Alvarez MP; Cano P; Jiménez V; Duvilanski B
Exp Brain Res; 2004 Aug; 157(3):296-302. PubMed ID: 14985901
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia diagnostics--dilemmas over optimal selection of prolactinemia time points.
Szosland K; Stasiak M; Lewiński A
Ann Agric Environ Med; 2015; 22(2):332-7. PubMed ID: 26094534
[TBL] [Abstract][Full Text] [Related]
18. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
[TBL] [Abstract][Full Text] [Related]
19. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
De Marinis L; Zuppi P; Valle D; Mancini A; Bianchi A; Lauriola L; Pasquini P; Anile C; Maira G; Giustina A
Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
